Skip to main content

Peer Review reports

From: Societal Costs and Benefits of Treatment with Trastuzumab in Patients with Early HER2neu-Overexpressing Breast Cancer in Singapore

Original Submission
10 Sep 2010 Submitted Original manuscript
14 Sep 2010 Author responded Author comments - Gilberto de Lima Lopes
Resubmission - Version 2
14 Sep 2010 Submitted Manuscript version 2
15 Nov 2010 Reviewed Reviewer Report - Athanasios Pallis
17 Nov 2010 Reviewed Reviewer Report - Evandro de Azambuja
23 Nov 2010 Reviewed Reviewer Report - Bruno Coudert
3 Dec 2010 Reviewed Reviewer Report - Manuela Joore
14 Mar 2011 Author responded Author comments - Gilberto de Lima Lopes
Resubmission - Version 3
14 Mar 2011 Submitted Manuscript version 3
6 Apr 2011 Reviewed Reviewer Report - Bruno Coudert
26 Apr 2011 Reviewed Reviewer Report - Manuela Joore
13 May 2011 Author responded Author comments - Gilberto de Lima Lopes
Resubmission - Version 4
13 May 2011 Submitted Manuscript version 4
Publishing
18 May 2011 Editorially accepted
18 May 2011 Article published 10.1186/1471-2407-11-178

You can find further information about peer review here.

Back to article page